What is the management and treatment for a patient diagnosed with Hellp (Hemolysis, Elevated Liver enzymes, and Low Platelet count) syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of HELLP Syndrome

Deliver the patient promptly after stabilizing blood pressure and correcting coagulopathy—HELLP syndrome only resolves after delivery, and delaying definitive treatment increases maternal mortality risk. 1, 2

Initial Stabilization and Diagnosis

Immediate Actions

  • Start IV magnesium sulfate immediately for seizure prophylaxis in all patients with HELLP syndrome and severe hypertension 2
  • Control blood pressure urgently if ≥160/90 mmHg using IV hydralazine or labetalol 1, 2
  • Transfer to ICU or high-dependency unit for continuous monitoring of blood pressure, oxygen saturation, ECG, and central venous pressure 2
  • Insert urinary catheter for hourly output monitoring (oliguria <400 mL/24h indicates severe disease) 1, 2

Essential Laboratory Workup

Obtain the following tests immediately to confirm diagnosis and assess severity 1:

  • Complete blood count with peripheral smear (platelet count <100,000/mm³ indicates active HELLP) 2
  • Liver function tests: AST, ALT, LDH, total bilirubin 2
  • Coagulation profile: PT, PTT, fibrinogen, fibrin degradation products 1
  • Renal function: creatinine, urea, uric acid 1
  • Urinalysis for proteinuria 1

Critical Imaging

  • Perform abdominal ultrasound or CT immediately if patient has right upper quadrant or epigastric pain (65% of symptomatic HELLP patients have this presentation) to rule out subcapsular hematoma or hepatic rupture 2
  • Obtain chest X-ray to exclude pulmonary edema 1

Blood Product Management

Platelet Transfusion Thresholds

  • Transfuse platelets if count <50,000/mm³, especially before cesarean section 1, 2
  • Strongly consider transfusion at higher platelet levels given increased bleeding risk 2
  • The degree of thrombocytopenia directly correlates with liver dysfunction severity and predicts adverse maternal outcomes 2

Red Blood Cell Transfusion

  • Transfuse whole blood or packed red cells if hemoglobin <10 g/dL 1, 3

Definitive Treatment: Delivery

Indications for Immediate Delivery

Proceed with delivery when any of the following are present 1:

  • Worsening pre-eclampsia or HELLP syndrome
  • Deteriorating hepatic or renal function
  • Severe thrombocytopenia (especially <50,000/mm³)
  • Gestational age ≥32-34 weeks
  • Evidence of fetal distress
  • Evidence of fetal lung maturity
  • Hepatic rupture or subcapsular hematoma 2

Mode of Delivery

  • Expect high cesarean section rates (61.5-76%) due to obstetric indications 1, 2
  • Do not delay delivery waiting for laboratory values to normalize—maternal mortality is 3.4% with delayed intervention 2

Anesthetic Considerations

Regional vs. General Anesthesia

  • Avoid regional anesthesia (epidural/spinal) if platelets <100,000/mm³ due to epidural hematoma risk 2
  • Spinal anesthesia is first choice for cesarean section if only moderate, non-progressive thrombocytopenia exists 4

General Anesthesia Technique (if required)

  • Use rapid sequence induction with suxamethonium for airway management 1
  • Select drugs with minimal hepatic/renal metabolism—propofol is recommended 1
  • Control hypertensive response to intubation aggressively to prevent cerebral complications 4
  • Anticipate difficult airway and have advanced airway equipment ready 4

Post-Delivery Management

Intensive Monitoring Period

  • Continue magnesium sulfate for 24 hours after delivery 3
  • Maintain strict fluid balance for 24 hours post-delivery to avoid pulmonary edema—avoid aggressive fluid resuscitation 3
  • Monitor laboratory values every 6-12 hours for at least 24-48 hours postpartum (30% of HELLP cases occur or worsen postpartum) 2

Blood Pressure Control

  • Continue antihypertensives: oral labetalol, nifedipine, or methyldopa for non-severe hypertension 3
  • Use IV labetalol or hydralazine for severe hypertension in monitored setting 3

Surveillance for Complications

Watch for the following life-threatening complications 1, 3:

  • Hepatic hemorrhage or hematoma (monitor for abdominal pain, epigastric pain, right shoulder pain)
  • Renal failure (monitor hourly urine output and creatinine)
  • Pulmonary edema (avoid fluid overload)
  • Hemorrhage (monitor hemoglobin and coagulation parameters)
  • DIC (monitor fibrinogen and platelet count)
  • Hypoglycemia (check glucose levels) 1, 3

Peak Disease Activity

  • HELLP syndrome intensity peaks 24 hours after delivery—maintain highest vigilance during this period 5

Critical Pitfalls to Avoid

  • Never use corticosteroids to improve maternal HELLP outcomes—they are ineffective for maternal disease 2, 3
  • Do not miss delayed diagnosis: symptoms mimic acute cholecystitis, drug reactions, idiopathic thrombocytopenia, appendicitis 1, 6
  • Do not perform invasive procedures (central lines, arterial lines) without correcting coagulopathy first 4
  • Markedly reduced platelet count (<20×10⁹/L) correlates with higher hepatic hemorrhage risk—escalate monitoring 3

Long-Term Counseling

  • Counsel regarding increased recurrence risk in future pregnancies 3
  • Consider aspirin prophylaxis in future pregnancies starting before 16 weeks' gestation 3

References

Guideline

Management of HELLP Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of HELLP Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Post-Emergent C-Section for Eclampsia and HELLP Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Anesthetic considerations in HELLP syndrome.

Acta anaesthesiologica Scandinavica, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.